Epidermal growth factor receptor (EGFR) is a type of protein, which is located on the surface of human body cells. Any mutation in EGFR gene can lead to various types of cancer. EGFR functions as a biomarker for non-small cell lung cancer (NSCLC) and due to the mutation of EGFR gene a person may suffer from cancer or may have a tumor growth. Tumors with genetically altered EGFR gene are referred to as EGFR-mutated tumors. EGFR mutation is generally observed in NSCLCs, especially in adenocarcinoma tumors. According to the International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society, there are around 50% of surgically resected lung adenocarcinomas in EGFR mutations. These mutations are related to micro papillary predominant subtype and the bronchioloalveolar carcinoma. EGFR biomarker is used in diagnosis of patients with NSCLC. Targeted therapy involving tyrosine kinase inhibitors such as gefitinib and erotinib is used in the treatment of patients with NSCLC. EGFR biomarker detects the presence of specific alterations in EGFR gene, which may lead to the development of tumor.

The global EGFR Mutation Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

Increasing global prevalence of lung cancer is expected to fuel growth of the global EGFR mutation test market over the forecast period. Increasing adoption of biomarker therapy is also expected to boost growth of the market worldwide over the forecast period.

This report aims to provide a comprehensive presentation of the global market for EGFR Mutation Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding EGFR Mutation Test.

Report Scope

The EGFR Mutation Test market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global EGFR Mutation Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the EGFR Mutation Test companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of EGFR Mutation Test Market Report

Report Metric	Details
Report Name	EGFR Mutation Test Market
Segment by Type	DNA Sequencing Kits
Segment by Application	Cancer Hospitals Clinical Research Institutes
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Merck, Thermo Fisher Scientific, Illumina, BioMerieux, QIAGEN, Agilent Technologies, Hologic, Novartis, Roche, Genomic Health
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of EGFR Mutation Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the EGFR Mutation Test Market report?

Ans: The main players in the EGFR Mutation Test Market are Abbott, Merck, Thermo Fisher Scientific, Illumina, BioMerieux, QIAGEN, Agilent Technologies, Hologic, Novartis, Roche, Genomic Health

What are the Application segmentation covered in the EGFR Mutation Test Market report?

Ans: The Applications covered in the EGFR Mutation Test Market report are Cancer Hospitals, Clinical Research Institutes

What are the Type segmentation covered in the EGFR Mutation Test Market report?

Ans: The Types covered in the EGFR Mutation Test Market report are DNA Sequencing, Kits

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global EGFR Mutation Test Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 DNA Sequencing

1.2.3 Kits

1.3 Market by Application

1.3.1 Global EGFR Mutation Test Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Cancer Hospitals

1.3.3 Clinical Research Institutes

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global EGFR Mutation Test Market Perspective (2019-2030)

2.2 EGFR Mutation Test Growth Trends by Region

2.2.1 Global EGFR Mutation Test Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 EGFR Mutation Test Historic Market Size by Region (2019-2024)

2.2.3 EGFR Mutation Test Forecasted Market Size by Region (2025-2030)

2.3 EGFR Mutation Test Market Dynamics

2.3.1 EGFR Mutation Test Industry Trends

2.3.2 EGFR Mutation Test Market Drivers

2.3.3 EGFR Mutation Test Market Challenges

2.3.4 EGFR Mutation Test Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top EGFR Mutation Test Players by Revenue

3.1.1 Global Top EGFR Mutation Test Players by Revenue (2019-2024)

3.1.2 Global EGFR Mutation Test Revenue Market Share by Players (2019-2024)

3.2 Global EGFR Mutation Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by EGFR Mutation Test Revenue

3.4 Global EGFR Mutation Test Market Concentration Ratio

3.4.1 Global EGFR Mutation Test Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by EGFR Mutation Test Revenue in 2023

3.5 EGFR Mutation Test Key Players Head office and Area Served

3.6 Key Players EGFR Mutation Test Product Solution and Service

3.7 Date of Enter into EGFR Mutation Test Market

3.8 Mergers & Acquisitions, Expansion Plans

4 EGFR Mutation Test Breakdown Data by Type

4.1 Global EGFR Mutation Test Historic Market Size by Type (2019-2024)

4.2 Global EGFR Mutation Test Forecasted Market Size by Type (2025-2030)

5 EGFR Mutation Test Breakdown Data by Application

5.1 Global EGFR Mutation Test Historic Market Size by Application (2019-2024)

5.2 Global EGFR Mutation Test Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America EGFR Mutation Test Market Size (2019-2030)

6.2 North America EGFR Mutation Test Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America EGFR Mutation Test Market Size by Country (2019-2024)

6.4 North America EGFR Mutation Test Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe EGFR Mutation Test Market Size (2019-2030)

7.2 Europe EGFR Mutation Test Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe EGFR Mutation Test Market Size by Country (2019-2024)

7.4 Europe EGFR Mutation Test Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific EGFR Mutation Test Market Size (2019-2030)

8.2 Asia-Pacific EGFR Mutation Test Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific EGFR Mutation Test Market Size by Region (2019-2024)

8.4 Asia-Pacific EGFR Mutation Test Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America EGFR Mutation Test Market Size (2019-2030)

9.2 Latin America EGFR Mutation Test Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America EGFR Mutation Test Market Size by Country (2019-2024)

9.4 Latin America EGFR Mutation Test Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa EGFR Mutation Test Market Size (2019-2030)

10.2 Middle East & Africa EGFR Mutation Test Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa EGFR Mutation Test Market Size by Country (2019-2024)

10.4 Middle East & Africa EGFR Mutation Test Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Detail

11.1.2 Abbott Business Overview

11.1.3 Abbott EGFR Mutation Test Introduction

11.1.4 Abbott Revenue in EGFR Mutation Test Business (2019-2024)

11.1.5 Abbott Recent Development

11.2 Merck

11.2.1 Merck Company Detail

11.2.2 Merck Business Overview

11.2.3 Merck EGFR Mutation Test Introduction

11.2.4 Merck Revenue in EGFR Mutation Test Business (2019-2024)

11.2.5 Merck Recent Development

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Detail

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific EGFR Mutation Test Introduction

11.3.4 Thermo Fisher Scientific Revenue in EGFR Mutation Test Business (2019-2024)

11.3.5 Thermo Fisher Scientific Recent Development

11.4 Illumina

11.4.1 Illumina Company Detail

11.4.2 Illumina Business Overview

11.4.3 Illumina EGFR Mutation Test Introduction

11.4.4 Illumina Revenue in EGFR Mutation Test Business (2019-2024)

11.4.5 Illumina Recent Development

11.5 BioMerieux

11.5.1 BioMerieux Company Detail

11.5.2 BioMerieux Business Overview

11.5.3 BioMerieux EGFR Mutation Test Introduction

11.5.4 BioMerieux Revenue in EGFR Mutation Test Business (2019-2024)

11.5.5 BioMerieux Recent Development

11.6 QIAGEN

11.6.1 QIAGEN Company Detail

11.6.2 QIAGEN Business Overview

11.6.3 QIAGEN EGFR Mutation Test Introduction

11.6.4 QIAGEN Revenue in EGFR Mutation Test Business (2019-2024)

11.6.5 QIAGEN Recent Development

11.7 Agilent Technologies

11.7.1 Agilent Technologies Company Detail

11.7.2 Agilent Technologies Business Overview

11.7.3 Agilent Technologies EGFR Mutation Test Introduction

11.7.4 Agilent Technologies Revenue in EGFR Mutation Test Business (2019-2024)

11.7.5 Agilent Technologies Recent Development

11.8 Hologic

11.8.1 Hologic Company Detail

11.8.2 Hologic Business Overview

11.8.3 Hologic EGFR Mutation Test Introduction

11.8.4 Hologic Revenue in EGFR Mutation Test Business (2019-2024)

11.8.5 Hologic Recent Development

11.9 Novartis

11.9.1 Novartis Company Detail

11.9.2 Novartis Business Overview

11.9.3 Novartis EGFR Mutation Test Introduction

11.9.4 Novartis Revenue in EGFR Mutation Test Business (2019-2024)

11.9.5 Novartis Recent Development

11.10 Roche

11.10.1 Roche Company Detail

11.10.2 Roche Business Overview

11.10.3 Roche EGFR Mutation Test Introduction

11.10.4 Roche Revenue in EGFR Mutation Test Business (2019-2024)

11.10.5 Roche Recent Development

11.11 Genomic Health

11.11.1 Genomic Health Company Detail

11.11.2 Genomic Health Business Overview

11.11.3 Genomic Health EGFR Mutation Test Introduction

11.11.4 Genomic Health Revenue in EGFR Mutation Test Business (2019-2024)

11.11.5 Genomic Health Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Abbott

Merck

Thermo Fisher Scientific

List of Tables

Table 1. Global EGFR Mutation Test Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of DNA Sequencing

Table 3. Key Players of Kits

Table 4. Global EGFR Mutation Test Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global EGFR Mutation Test Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global EGFR Mutation Test Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global EGFR Mutation Test Market Share by Region (2019-2024)

Table 8. Global EGFR Mutation Test Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global EGFR Mutation Test Market Share by Region (2025-2030)

Table 10. EGFR Mutation Test Market Trends

Table 11. EGFR Mutation Test Market Drivers

Table 12. EGFR Mutation Test Market Challenges

Table 13. EGFR Mutation Test Market Restraints

Table 14. Global EGFR Mutation Test Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global EGFR Mutation Test Market Share by Players (2019-2024)

Table 16. Global Top EGFR Mutation Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in EGFR Mutation Test as of 2023)

Table 17. Ranking of Global Top EGFR Mutation Test Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by EGFR Mutation Test Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players EGFR Mutation Test Product Solution and Service

Table 21. Date of Enter into EGFR Mutation Test Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global EGFR Mutation Test Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global EGFR Mutation Test Revenue Market Share by Type (2019-2024)

Table 25. Global EGFR Mutation Test Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global EGFR Mutation Test Revenue Market Share by Type (2025-2030)

Table 27. Global EGFR Mutation Test Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global EGFR Mutation Test Revenue Market Share by Application (2019-2024)

Table 29. Global EGFR Mutation Test Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global EGFR Mutation Test Revenue Market Share by Application (2025-2030)

Table 31. North America EGFR Mutation Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America EGFR Mutation Test Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America EGFR Mutation Test Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe EGFR Mutation Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe EGFR Mutation Test Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe EGFR Mutation Test Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific EGFR Mutation Test Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific EGFR Mutation Test Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific EGFR Mutation Test Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America EGFR Mutation Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America EGFR Mutation Test Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America EGFR Mutation Test Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa EGFR Mutation Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa EGFR Mutation Test Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa EGFR Mutation Test Market Size by Country (2025-2030) & (US$ Million)

Table 46. Abbott Company Detail

Table 47. Abbott Business Overview

Table 48. Abbott EGFR Mutation Test Product

Table 49. Abbott Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)

Table 50. Abbott Recent Development

Table 51. Merck Company Detail

Table 52. Merck Business Overview

Table 53. Merck EGFR Mutation Test Product

Table 54. Merck Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)

Table 55. Merck Recent Development

Table 56. Thermo Fisher Scientific Company Detail

Table 57. Thermo Fisher Scientific Business Overview

Table 58. Thermo Fisher Scientific EGFR Mutation Test Product

Table 59. Thermo Fisher Scientific Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)

Table 60. Thermo Fisher Scientific Recent Development

Table 61. Illumina Company Detail

Table 62. Illumina Business Overview

Table 63. Illumina EGFR Mutation Test Product

Table 64. Illumina Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)

Table 65. Illumina Recent Development

Table 66. BioMerieux Company Detail

Table 67. BioMerieux Business Overview

Table 68. BioMerieux EGFR Mutation Test Product

Table 69. BioMerieux Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)

Table 70. BioMerieux Recent Development

Table 71. QIAGEN Company Detail

Table 72. QIAGEN Business Overview

Table 73. QIAGEN EGFR Mutation Test Product

Table 74. QIAGEN Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)

Table 75. QIAGEN Recent Development

Table 76. Agilent Technologies Company Detail

Table 77. Agilent Technologies Business Overview

Table 78. Agilent Technologies EGFR Mutation Test Product

Table 79. Agilent Technologies Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)

Table 80. Agilent Technologies Recent Development

Table 81. Hologic Company Detail

Table 82. Hologic Business Overview

Table 83. Hologic EGFR Mutation Test Product

Table 84. Hologic Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)

Table 85. Hologic Recent Development

Table 86. Novartis Company Detail

Table 87. Novartis Business Overview

Table 88. Novartis EGFR Mutation Test Product

Table 89. Novartis Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)

Table 90. Novartis Recent Development

Table 91. Roche Company Detail

Table 92. Roche Business Overview

Table 93. Roche EGFR Mutation Test Product

Table 94. Roche Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)

Table 95. Roche Recent Development

Table 96. Genomic Health Company Detail

Table 97. Genomic Health Business Overview

Table 98. Genomic Health EGFR Mutation Test Product

Table 99. Genomic Health Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)

Table 100. Genomic Health Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Global EGFR Mutation Test Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global EGFR Mutation Test Market Share by Type: 2023 VS 2030

Figure 3. DNA Sequencing Features

Figure 4. Kits Features

Figure 5. Global EGFR Mutation Test Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global EGFR Mutation Test Market Share by Application: 2023 VS 2030

Figure 7. Cancer Hospitals Case Studies

Figure 8. Clinical Research Institutes Case Studies

Figure 9. EGFR Mutation Test Report Years Considered

Figure 10. Global EGFR Mutation Test Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global EGFR Mutation Test Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global EGFR Mutation Test Market Share by Region: 2023 VS 2030

Figure 13. Global EGFR Mutation Test Market Share by Players in 2023

Figure 14. Global Top EGFR Mutation Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in EGFR Mutation Test as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by EGFR Mutation Test Revenue in 2023

Figure 16. North America EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America EGFR Mutation Test Market Share by Country (2019-2030)

Figure 18. United States EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. Canada EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Europe EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe EGFR Mutation Test Market Share by Country (2019-2030)

Figure 22. Germany EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. France EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. U.K. EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Italy EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Russia EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Nordic Countries EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Asia-Pacific EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific EGFR Mutation Test Market Share by Region (2019-2030)

Figure 30. China EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Japan EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. South Korea EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Southeast Asia EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. India EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Australia EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Latin America EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America EGFR Mutation Test Market Share by Country (2019-2030)

Figure 38. Mexico EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Brazil EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa EGFR Mutation Test Market Share by Country (2019-2030)

Figure 42. Turkey EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Saudi Arabia EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Abbott Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)

Figure 45. Merck Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)

Figure 46. Thermo Fisher Scientific Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)

Figure 47. Illumina Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)

Figure 48. BioMerieux Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)

Figure 49. QIAGEN Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)

Figure 50. Agilent Technologies Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)

Figure 51. Hologic Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)

Figure 52. Novartis Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)

Figure 53. Roche Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)

Figure 54. Genomic Health Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions